Bill
A 5157
Bill A 5157 eliminates co-pays for short-term opioid prescriptions, making pain management more affordable for patients and easing financial burdens on their healthcare.
Bill Number: A 5157
Title: Prohibits Co-Pays for Certain Short Term Opioid Drug Prescriptions
Status: Referred to Insurance
Introduced: February 12, 2025
Classification: Bill
Bill A 5157 aims to alleviate the financial burden on patients who are prescribed short-term opioid medications. The primary intent is to prohibit insurance companies from imposing co-pays on these prescriptions, thereby making necessary pain management more accessible and affordable for patients.
Co-Pay Prohibition: The bill specifically prohibits health insurance plans from requiring co-pays for short-term opioid prescriptions. This includes medications prescribed for acute pain management, such as post-surgical recovery or injury-related pain.
Definition of Short-Term Opioids: The bill defines "short-term opioid prescriptions" as those intended for use over a limited duration, typically not exceeding a specified number of days (the exact duration may be defined in further legislative details or regulations).
Insurance Compliance: Insurance providers will be required to adjust their policies to comply with this prohibition, ensuring that patients can obtain prescribed opioids without additional out-of-pocket costs.
Patients: Individuals prescribed short-term opioids for pain management will benefit directly from the elimination of co-pays, making it easier for them to access necessary medications without financial strain.
Healthcare Providers: Physicians and healthcare practitioners may see an increase in patient compliance with prescribed treatments, as cost barriers are reduced.
Insurance Companies: Insurers will need to revise their policies and potentially adjust their pricing structures to accommodate this change in co-pay requirements.
Current Status: As of February 12, 2025, the bill has been referred to the Insurance Committee for further consideration.
Related Legislation: This bill is part of a broader legislative effort to address opioid prescription practices, with several related bills from prior sessions (A 10435, A 3528, A 6139, A 3903, A 3476) and a companion bill in the Senate (S 2315) indicating ongoing legislative interest in opioid management and insurance practices.
Bill A 5157 represents a significant step towards improving access to necessary pain management for patients requiring short-term opioid prescriptions. By eliminating co-pays, the bill seeks to reduce financial barriers and promote better health outcomes for individuals dealing with acute pain. The bill is currently under review by the Insurance Committee, and its progress will be closely monitored by stakeholders in the healthcare and insurance sectors.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
